» Articles » PMID: 30847469

In Vivo Imaging Reveals Reduced Activity of Neuronal Circuits in a Mouse Tauopathy Model

Overview
Journal Brain
Specialty Neurology
Date 2019 Mar 9
PMID 30847469
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Pathological alterations of tau protein play a significant role in the emergence and progression of neurodegenerative disorders. Tauopathies are characterized by detachment of the tau protein from neuronal microtubules, and its subsequent aberrant hyperphosphorylation, aggregation and cellular distribution. The exact nature of tau protein species causing neuronal malfunction and degeneration is still unknown. In the present study, we used mice transgenic for human tau with the frontotemporal dementia with parkinsonism-associated P301S mutation. These mice are prone to develop fibrillar tau inclusions, especially in the spinal cord and brainstem. At the same time, cortical neurons are not as strongly affected by fibrillar tau forms, but rather by soluble tau forms. We took advantage of the possibility to induce formation of neurofibrillary tangles in a subset of these cortical neurons by local injection of preformed synthetic tau fibrils. By using chronic in vivo two-photon calcium imaging in awake mice, we were able for the first time to follow the activity of individual tangle-bearing neurons and compare it to the activity of tangle-free neurons over the disease course. Our results revealed strong reduction of calcium transient frequency in layer 2/3 cortical neurons of P301S mice, independent of neurofibrillary tangle presence. These results clearly point to the impairing role of soluble, mutated tau protein species present in the majority of the neurons investigated in this study.

Citing Articles

HCN2 deficiency correlates with memory deficits and hyperexcitability of dCA1 pyramidal neurons in Alzheimer's disease.

Zhang X, Zhang Y, Zhang T, Wang J, Liu C, Shang Q Alzheimers Res Ther. 2025; 17(1):55.

PMID: 40016780 PMC: 11866685. DOI: 10.1186/s13195-025-01704-y.


Functional network disruption in cognitively unimpaired autosomal dominant Alzheimer's disease: a magnetoencephalography study.

van Nifterick A, de Haan W, Stam C, Hillebrand A, Scheltens P, Van Kesteren R Brain Commun. 2024; 6(6):fcae423.

PMID: 39713236 PMC: 11660908. DOI: 10.1093/braincomms/fcae423.


Alzheimer's disease induced neurons bearing mutations exhibit reduced excitability.

Maksour S, Finol-Urdaneta R, Hulme A, Cabral-da-Silva M, Targa Dias Anastacio H, Balez R Front Cell Neurosci. 2024; 18:1406970.

PMID: 39444394 PMC: 11497635. DOI: 10.3389/fncel.2024.1406970.


Neuronal hypofunction and network dysfunction in a mouse model at an early stage of tauopathy.

Ji C, Yang X, Eleish M, Jiang Y, Tetlow A, Song S Alzheimers Dement. 2024; 20(11):7954-7970.

PMID: 39368113 PMC: 11567809. DOI: 10.1002/alz.14273.


AAV8-P301L tau expression confers age-related disruptions in sleep quantity and timing.

Alava B, Morris A, Liu A, Abisambra J, Esser K NPJ Biol Timing Sleep. 2024; 1(1):8.

PMID: 39363957 PMC: 11445076. DOI: 10.1038/s44323-024-00009-x.